Actively Recruiting
Myeloma Registry Platform (MYRIAM)
Led by iOMEDICO AG · Updated on 2026-01-27
2200
Participants Needed
1
Research Sites
583 weeks
Total Duration
On this page
Sponsors
I
iOMEDICO AG
Lead Sponsor
D
Deutsche Studiengruppe Multiples Myelom (DSMM)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Multiple Myeloma in Germany.
CONDITIONS
Official Title
Myeloma Registry Platform (MYRIAM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Multiple Myeloma requiring systemic treatment (first-, second-, or third-line; recruitment closed for first- and second-line)
- Age 18 years or older
- Written informed consent provided
- For patients in the PRO satellite: consent and baseline questionnaire completed within eight weeks before starting systemic treatment
- For patients not in the PRO satellite: consent given no later than four weeks after treatment start, and not more than eight weeks before treatment start
- Sufficient German language skills for participation in the PRO satellite
You will not qualify if you...
- No systemic therapy planned for Multiple Myeloma
- Currently enrolled in other studies that prohibit participation in this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Multiple sites all over germany
Multiple Sites, Germany
Actively Recruiting
Research Team
M
Martina Jänicke, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here